Skip to content

Clinical study of modified emulsion gel of Swarjikadi Avartana Ghrita for Normalizing Hyperpigmentation of Scar Mark

Pharmaceutico-analytical study of Swarjikadi Avartana Ghrita modified into emulsion gel for savarnikarana of Vranavastu w.s.r to cicatrix:A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104740
Enrollment
64
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L905- Scar conditions and fibrosis of skin

Interventions

None listed

Sponsors

Dr. Sejal Rajendra Asati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willingly participating in the trial and giving consent form. 2.Patients with scar or pigmentation of skin after wound healing. 3.Patient included with Accidental scar, Burn scar(2nd degree)and Post operative scar. 4.Both male and female patients are included 5.Scar location: Any part of the body except genitals and mucosal areas. 6.Stable scars with no active infection or ulceration

Exclusion criteria

Exclusion criteria: 1.Keloid scars (as they may require separate therapeutic approaches). 2.Burn 3rd and 4th degree 3.History of hypersensitivity or allergy to any ingredient of Swarjikadi Ghrita. 4.Patients suffering from skin disease like leucoderma, leprosy. 5.Malignancy

Design outcomes

Primary

MeasureTime frame
1.To study the pharmaceutical procedure of Swarjikadi Avartana Ghrita and its emlusion gel. 2.To analyze organoleptic and physico-chemical parameters of Swarjikadi Avartana Ghrita and its emulsion gel. 3.To clinically evaluate and compare the effect of modified emulsion gel of Swarjikadi Avartana Ghrita and Manjishtha Lepa for Savarnikarana of Vranavastu. Timepoint: follow up 7th,14th,,28th days

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDrRaman Belge

Shri Ayurved Mahavidyalaya, Nagpu

ramanbelge@gmail.com9822879010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026